UTRECHT, The Netherlands and PHILADELPHIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (LVTX) (NASDAQ: LVTX, “LAVA,” “the Company”), a clinical-stage immuno-oncology company focused on ...
LONDON, May 3, 2017 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/4882436/ Description The Global Option and Evaluation Partnering ...
(RTTNews) - National Instruments Corp. (NATI) Thursday announced the initiation of a review and evaluation of strategic options with the intent to unlock and maximize shareholder value. The ...
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of ...
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--HanesBrands (NYSE: HBI) today announced that its Board of Directors and executive leadership team, with the assistance of financial and legal advisors, are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results